Abstract
It is rare for a full-fledged malignancy cytogenetics service to be started as a result of a policy decision and business plan. More often it grows from a small beginning: perhaps just one or two research assistants working on the particular interest of an oncologist, or perhaps one or two people in a preexisting general cytogenetics laboratory specializing in malignancy cytogenetics instead of the malignancy samples being shared equally between everyone. Because genetic studies of many types of malignancy are still in their early stages, then the research element is often prominent. As the findings are published and confirmed and become clinically useful, then research funding is likely to become unobtainable as the work is deemed to have become a service and should therefore be funded in the same way as other well-established clinical services such as hematology and biochemistry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Panagopoulos, I., Mertens, F., Isaksson, M., et al. (2001) Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31, 362–372.
Tobal, K., Saunders, M. J., Grey, M. R., and Yin, J. A. (1995) Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukemia. Br. J. Haematol. 90, 615–618.
Diverio, D., Rossi, V., Avvisati, G., et al. (1998) Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter “AIDA” trial. GIMEMA-AIEOP Multicenter “AIDA” Trial. Blood 92, 784–789.
Zhao, L., Chang, K. S., Estey, E. H., Hayes, K., Deisseroth, A. B., and Liang, J. C. (1995) Detection of residual leukemic cells in patients with acute promyelocytic leukemia by the fluorescence in situ hybridization method: potential for predicting relapse. Blood 85, 495–499.
Kolomietz, E., Al-Maghrabi, J., Brennan, S., et al.(2001) Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97, 3581–3588.
Strefford, J. C., Lillington, D. M., Young, B. D., and Oliver, R. T. D. (2001) The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data. Cancer Genet. Cytogenet, 124, 112–121.
Barth, T. F., Benner, A., Bentz, M., Dohner, H., Moller, P., and Lichter, P. (2000) Risk of false positive results in comparative genomic hybridization. Genes Chromosomes Cancer 28, 353–357.
Biernaux, C., Loos, M., Sels, A., Huez, G., and Stryckmans, P. (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86, 3118–3122.
Muller, J. R., Janz, S., Goedert, J. J., Potter, M., and Rabkin, C. S. (1995) Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc. Natl. Acad. Sci. USA 92, 6577–6581.
Dolken, G., Illerhaus, G., Hirt, C., and Mertelsmann, R. (1996) BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J. Clin. Oncol. 14, 1333–1244.
Marcucci, G., Strout, M. P., Bloomfield, C. D., and Caliguri, M. A. (1998) Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Res. 58, 790–793.
Uckun, F. M., Herman-Hatten, K., Crotty, M. L., et al. (1998) Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 92, 810–821.
Hunger, S. P., and Cleary, M. L. (1998) Commentary: what significance should we attribute to the detection of MLL fusion transcripts? Blood 92, 709–711.
Tajiri, T., Shono, K., Fujii, Y., et al. (1999) Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization. J. Pediatr. Surg. 34, 1615–1619.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Swansbury, J. (2003). Some Difficult Choices in Cytogenetics. In: Swansbury, J. (eds) Cancer Cytogenetics. Methods in Molecular Biology™, vol 220. Humana Press. https://doi.org/10.1385/1-59259-363-1:245
Download citation
DOI: https://doi.org/10.1385/1-59259-363-1:245
Publisher Name: Humana Press
Print ISBN: 978-1-58829-080-9
Online ISBN: 978-1-59259-363-7
eBook Packages: Springer Protocols